Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-14 · accession 0001104659-26-029712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-14 | ARMP | Kyme Pierre | Chief Business Off | F - Tax | $10.54 | -1,030 | 9,461 | -10% | -$10.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-14 | F | D | 1,030 | $10.54 | 9,461 | D | — | — | (F1) Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units. |